Russell Investments Group, Ltd. Denali Therapeutics Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 21,974 shares of DNLI stock, worth $552,865. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,974

Previous 22,914 4.1%

Holding current value

$552,865

Previous $532,000 20.3%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$20.96 - $31.05 $19,702 - $29,187	-940 Reduced 4.1%	21,974 $640,000
Q2 2024 Aug 08, 2024	SELL	$14.96 - $23.22 $938,201 - $1.46 Million	-62,714 Reduced 73.24%	22,914 $532,000
Q1 2024 May 08, 2024	SELL	$15.83 - $23.35 $409,126 - $603,480	-25,845 Reduced 23.18%	85,628 $1.76 Million
Q4 2023 Feb 05, 2024	SELL	$16.2 - $23.18 $41,877 - $59,920	-2,585 Reduced 2.27%	111,473 $2.39 Million
Q3 2023 Nov 13, 2023	BUY	$20.63 - $30.17 $149,443 - $218,551	7,244 Added 6.78%	114,058 $2.35 Million
Q2 2023 Aug 10, 2023	BUY	$23.37 - $32.96 $573,009 - $808,146	24,519 Added 29.79%	106,814 $3.15 Million
Q1 2023 May 09, 2023	SELL	$21.91 - $32.67 $374,178 - $557,938	-17,078 Reduced 17.19%	82,295 $1.9 Million
Q4 2022 Feb 08, 2023	SELL	$26.28 - $33.92 $196,784 - $253,992	-7,488 Reduced 7.01%	99,373 $2.76 Million
Q3 2022 Nov 04, 2022	BUY	$25.97 - $38.53 $483,847 - $717,852	18,631 Added 21.12%	106,861 $3.28 Million
Q2 2022 Jul 29, 2022	BUY	$20.88 - $35.19 $766,504 - $1.29 Million	36,710 Added 71.25%	88,230 $2.6 Million
Q1 2022 May 05, 2022	SELL	$29.0 - $47.27 $423,429 - $690,189	-14,601 Reduced 22.08%	51,520 $1.66 Million
Q4 2021 Jan 21, 2022	BUY	$42.59 - $55.02 $32,794 - $42,365	770 Added 1.18%	66,121 $2.95 Million
Q3 2021 Nov 08, 2021	BUY	$48.48 - $78.23 $77,277 - $124,698	1,594 Added 2.5%	65,351 $3.28 Million
Q2 2021 Aug 04, 2021	BUY	$50.3 - $78.44 $794,287 - $1.24 Million	15,791 Added 32.92%	63,757 $4.99 Million
Q1 2021 May 10, 2021	SELL	$53.8 - $81.53 $1.73 Million - $2.62 Million	-32,129 Reduced 40.11%	47,966 $2.73 Million
Q4 2020 Feb 08, 2021	BUY	$36.89 - $93.56 $940,547 - $2.39 Million	25,496 Added 46.7%	80,095 $6.71 Million
Q2 2020 Aug 05, 2020	SELL	$16.01 - $28.82 $274,251 - $493,686	-17,130 Reduced 23.88%	54,599 $1.32 Million
Q1 2020 May 06, 2020	SELL	$14.2 - $27.98 $641,698 - $1.26 Million	-45,190 Reduced 38.65%	71,729 $1.26 Million
Q4 2019 Jan 29, 2020	BUY	$14.4 - $19.99 $688,262 - $955,442	47,796 Added 69.15%	116,919 $2.04 Million
Q3 2019 Nov 01, 2019	BUY	$15.32 - $21.92 $514,491 - $736,139	33,583 Added 94.49%	69,123 $1.06 Million
Q2 2019 Aug 09, 2019	BUY	$18.5 - $28.14 $178,525 - $271,551	9,650 Added 37.27%	35,540 $736,000
Q1 2019 May 13, 2019	BUY	$17.99 - $24.65 $163,601 - $224,167	9,094 Added 54.14%	25,890 $601,000
Q4 2018 Feb 11, 2019	BUY	$13.88 - $21.75 $233,128 - $365,313	16,796 New	16,796 $347,000

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.38B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Denali Therapeutics Inc. Transaction History